Simian adenoviruses as vaccine vectors

Simian adenoviruses as vaccine vectors

Taispeáin leaganacha eile (1)

Replication incompetent human adenovirus serotype 5 (HAdV-C5) has been extensively used as a delivery vehicle for gene therapy proteins and infectious disease antigens. These vectors infect replicating and nonreplicating cells, have a broad tissue tropism, elicit high immune responses and are easily...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Morris, S, Sebastian, S, Spencer, A, Gilbert, S
Formáid:	Journal article
Foilsithe / Cruthaithe:	Future Medicine 2016

Míreanna comhchosúla

Simian adenoviruses as vaccine vectors
de réir: Morris, S, et al.
Foilsithe / Cruthaithe: (2016)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
de réir: Folegatti, P, et al.
Foilsithe / Cruthaithe: (2019)

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector.
de réir: O'Hara, G, et al.
Foilsithe / Cruthaithe: (2012)

Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine
de réir: Pedro M. Folegatti, et al.
Foilsithe / Cruthaithe: (2019-05-01)

Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology
de réir: Gilbert, S, et al.
Foilsithe / Cruthaithe: (2017)

The Biodistribution of Replication-Defective Simian Adenovirus 1 Vector in a Mouse Model
de réir: Juan Chen, et al.
Foilsithe / Cruthaithe: (2024-03-01)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved influenza a antigens
de réir: Antrobus, R, et al.
Foilsithe / Cruthaithe: (2014)

Clinical assessment of a novel recombinant simian adenovirus ChAdOx1 as a vectored vaccine expressing conserved Influenza A antigens.
de réir: Antrobus, R, et al.
Foilsithe / Cruthaithe: (2014)

Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species.
de réir: Colloca, S, et al.
Foilsithe / Cruthaithe: (2012)

Heterologous two-dose vaccination with simian adenovirus and poxvirus vectors elicits long-lasting cellular immunity to influenza virus A in healthy adults
de réir: Coughlan, L, et al.
Foilsithe / Cruthaithe: (2018)

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults
de réir: L. Coughlan, et al.
Foilsithe / Cruthaithe: (2018-03-01)

A novel simian adenovirus-vectored COVID-19 vaccine elicits effective mucosal and systemic immunity in mice by intranasal and intramuscular vaccination regimens
de réir: Panli Zhang, et al.
Foilsithe / Cruthaithe: (2023-12-01)

A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis
de réir: Wang, C, et al.
Foilsithe / Cruthaithe: (2018)

A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
de réir: Chuan Wang, et al.
Foilsithe / Cruthaithe: (2018-10-01)

Simian adenovirus vector production for early-phase clinical trials: A simple method applicable to multiple serotypes and using entirely disposable product-contact components
de réir: Fedosyuk, S, et al.
Foilsithe / Cruthaithe: (2019)

A pan-genotype HCV T cell vaccine, in a simian adenovirus vector, to target T cell epitopes conserved across multiple HCV genotypes
de réir: Donnison, T, et al.
Foilsithe / Cruthaithe: (2018)

Simian adenoviruses: Molecular and serological survey in monkeys and humans in Thailand
de réir: Nathamon Kosoltanapiwat, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Single-dose protection against Plasmodium berghei by a simian adenovirus vector using a human cytomegalovirus promoter containing intron A.
de réir: Sridhar, S, et al.
Foilsithe / Cruthaithe: (2008)

A high infectious simian adenovirus type 23 vector based vaccine efficiently protects common marmosets against Zika virus infection.
de réir: Shengxue Luo, et al.
Foilsithe / Cruthaithe: (2020-02-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
de réir: Dicks, M, et al.
Foilsithe / Cruthaithe: (2013)

Novel adenovirus vaccine vectors
de réir: Dicks, M
Foilsithe / Cruthaithe: (2013)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
de réir: Dicks, M, et al.
Foilsithe / Cruthaithe: (2011)

Isolation of a novel monkey adenovirus reveals a new phylogenetic clade in the evolutionary history of simian adenoviruses
de réir: Bofill-Mas Silvia, et al.
Foilsithe / Cruthaithe: (2011-03-01)

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
de réir: Capucci, S, et al.
Foilsithe / Cruthaithe: (2017)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
de réir: Marta Ulaszewska, et al.
Foilsithe / Cruthaithe: (2023-01-01)

HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
de réir: Silvia Capucci, et al.
Foilsithe / Cruthaithe: (2017-01-01)

EVALUATION OF SIMIAN ADENOVIRAL VECTOR ADCH63 EXPRESSING MSP-1 AS A CANDIDATE BLOOD-STAGE MALARIA VACCINE
de réir: Goodman, A, et al.
Foilsithe / Cruthaithe: (2009)

A Novel Simian Adenovirus Associating with Human Adenovirus Species G Isolated from Long-Tailed Macaque Feces
de réir: Nathamon Kosoltanapiwat, et al.
Foilsithe / Cruthaithe: (2023-06-01)

HIV-1-neutralizing antibody 1 induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers
de réir: Capucci, S, et al.
Foilsithe / Cruthaithe: (2017)

Modification of Adenovirus vaccine vector-induced immune responses by expression of a signalling molecule
de réir: Rollier, CS, et al.
Foilsithe / Cruthaithe: (2020)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
de réir: Blasi M, et al.
Foilsithe / Cruthaithe: (2012-09-01)

Correction: HIV-1-neutralizing antibody induced by simian adenovirus- and poxvirus MVA-vectored BG505 native-like envelope trimers.
de réir: Silvia Capucci, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Combined intranasal and intramuscular parainfluenza 5-, simian adenovirus ChAdOx1- and poxvirus MVA-vectored vaccines induce synergistically HIV-1-specific T cells in the mucosa
de réir: Ashley C. Beavis, et al.
Foilsithe / Cruthaithe: (2023-07-01)

IL-10 Receptor Blockade Enhances CD4 and CD8 T Cell Responses to a Simian Adenovirus-Vectored HIV-1 Vaccine, ChAdV63.HIVconsv
de réir: Clutton, G, et al.
Foilsithe / Cruthaithe: (2013)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
de réir: Negri Donatella RM, et al.
Foilsithe / Cruthaithe: (2012-08-01)

MAIT cell activation augments adenovirus vector vaccine immunogenicity
de réir: Provine, N, et al.
Foilsithe / Cruthaithe: (2021)

Rapid-response manufacturing of adenovirus-vectored vaccines
de réir: Joe, CCD, et al.
Foilsithe / Cruthaithe: (2023)

Novel Adenovirus Vector-Based Vaccines for HIV
de réir: Letvin N, et al.
Foilsithe / Cruthaithe: (2005-12-01)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
de réir: Warimwe, G, et al.
Foilsithe / Cruthaithe: (2013)

P17-20. Lentiviral vector-based vaccine against SIV infection and simian AIDS
de réir: Bauche C, et al.
Foilsithe / Cruthaithe: (2009-10-01)